This topic contains a solution. Click here to go to the answer

Author Question: A nurse is caring for an African American patient with severe hemophilia A who has been admitted for ... (Read 30 times)

jerry coleman

  • Hero Member
  • *****
  • Posts: 570
A nurse is caring for an African American patient with severe hemophilia A who has been admitted for bleeding into the knee joint. The prescriber has ordered intravenous factor VIIa NovoSeven RT.
 
  A nursing student wants to know why this patient is not receiving factor VIII. Which statement by the nurse is correct? a. Factor VIIa is stronger than factor VIII and will work faster.
  b. Factor VIII is used for prophylaxis, and factor VIIa is used for acute episodes.
  c. Factor VIIa is used when patients devel-op antibodies against factor VIII.
  d. Factor VIIa provides immune tolerance therapy so that factor VIII will be more effective.

Question 2

A child with hemophilia A who weighs 30 kg receives factor VIII on an ongoing basis as prophylaxis. The provider orders desmopressin Stimate to be used for nosebleeds.
 
  The nurse will instruct the child's parents to give the medication as ____ nostril as needed. a. 1 spray in each
  b. 1 spray in one
  c. 2 sprays in each
  d. 2 sprays in one



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tanna.moeller

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

C
When patients develop antibodies against factor VIII, activated factor VII is used, because it has the same actions as factor VIII. Patients with severe hemophilia A have a 20 to 30 likelihood of developing antibodies to factor VIII and the risk of inhibitor development is unusually high in African American and Hispanic patients, so this patient has an increased risk. Factor VIIa is not stronger than factor VIII. It is not used for prophylaxis only. Immune tolerance therapy describes the use of repeated administration of factor replacement products to eliminate inhibitor produc-tion.

Answer to Question 2

B
Children who weigh less than 50 kg should use 1 spray in one nostril for a dose of 150 mcg. Each spray delivers 150 mcg, so 1 spray in both nostrils would give a dose of 300 mcg. Using 2 sprays in one nostril would give a dose of 300 mcg; using 2 sprays in both nostrils would give a dose of 600 mcg.




jerry coleman

  • Member
  • Posts: 570
Reply 2 on: Jul 23, 2018
Wow, this really help


Jossy

  • Member
  • Posts: 336
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

The cure for trichomoniasis is easy as long as the patient does not drink alcoholic beverages for 24 hours. Just a single dose of medication is needed to rid the body of the disease. However, without proper precautions, an individual may contract the disease repeatedly. In fact, most people develop trichomoniasis again within three months of their last treatment.

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Drug-induced pharmacodynamic effects manifested in older adults include drug-induced renal toxicity, which can be a major factor when these adults are experiencing other kidney problems.

Did you know?

Malaria mortality rates are falling. Increased malaria prevention and control measures have greatly improved these rates. Since 2000, malaria mortality rates have fallen globally by 60% among all age groups, and by 65% among children under age 5.

For a complete list of videos, visit our video library